Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Offer a clear, concise explanation of what an index fund is, how it works, and what investors should consider when using them.
13,305 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
As markets wobble in 2026, investors are turning to a core portfolio cornerstone built on durable, recurring revenue....
A globe-trotting investor proves you don’t need hundreds of doors to fund your freedom. With three well-chosen rental...
As AI momentum grows, savvy investors look for a foothold before Anthropic goes public. This guide breaks down three ...
Investors over 50 are recalibrating away from crowded AI bets toward dividend growth and quality stocks that pay risi...
Investors watched Alphabet slide as news of AI talent exits raised questions about leadership and the pace of AI inve...
Bitcoin weakness pushes STRC to new lows as strategy's Saylor acknowledges 'volatility' as a real market test. This g...
OpenAI accelerates its shift from software to silicon and bio bets, unveiling a custom chip, a DRAM stake, and a majo...
The space economy is expanding, yet investing in it without a plan can blow up portfolios. This guide explains why wa...
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...
BlackRock’s IBIT drew about $209 million in a single session, helping U.S. spot Bitcoin ETFs turn positive again. Mar...